MedTrace Logo

Fertility Protection for Children, Adolescents and Young Adults

NCT06692868 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-01-16

No results posted yet for this study

Summary

This study focuses on improving fertility preservation and long-term care for children, adolescents, and young adults (CAYA) undergoing cancer treatments or stem cell transplantation. These treatments can harm fertility, and ensuring that patients receive the right support and follow-up care is critical.

The main study goals are:

1. Understanding Fertility Risks: Researchers aim to identify factors that predict fertility problems after cancer treatments, such as the type of therapy, hormone levels, body composition, or genetic predispositions.
2. Addressing Patient and Family Needs: The program will explore the concerns, needs, and challenges faced by young patients and their parents regarding fertility. It will also examine how these issues affect their quality of life.
3. Improving Clinical Care: Current practices in fertility preservation and counseling will be studied to identify gaps and improve care structures.

To achieve these goals, the program will:

* Create a database to collect and analyze medical data from patients before, during, and after cancer treatments.
* Study the prevalence and long-term effects of fertility problems in young patients.
* Document medical interventions like fertility preservation methods (e.g., freezing eggs or sperm) and treatments for late effects.
* Assess patients' and families' fertility-related quality of life and their informational needs.

Ultimately, the project aims to establish an interdisciplinary center to support fertility preservation and improve the quality of care for young patients facing cancer and its treatments.

Conditions

  • Stem Cell Transplant
  • Stem Cell Transplantation
  • Oncological Outcomes
  • Oncological Patients
  • Oncological Children
  • Fertility
  • Fertility Protection
  • Endocrinological Late-effects
  • Paediatric Oncology
  • CAYA
  • Survivors

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • University of Ulm

    lead OTHER

Principal Investigators

  • Christian Denzer, Prof. Dr. · Ulm University Medical Centre - Division of Paediatric Endocrinology and Diabetes

  • Martin Wabitsch, Prof. Dr. · Ulm University Medical Centre - Division of Paediatric Endocrinology and Diabetes

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-09
Primary Completion
2044-11-30
Completion
2044-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06692868 on ClinicalTrials.gov